February MDM is Tuesday 28th... members off duty are encouraged to attend... 

Home
About Us
Red Ensign Campaign
National Conference 2011
Enquiries & Contacts
Industry Sectors
News, Reports & Publications
Health, Safety & Welfare
Lifeboat Accidents & Drill
Asbestos
Electrical Work
Industrial Deafness
What YOU can do!
Career Path to Marine Engineer Officer
Offshore Oil & Gas Agrement 2010
Warnings, Alerts, Advice
Engineer Officer Training Issues
On Watch
Elections
Shipping Reform
Members Entrance


AIMPE to establish asbestos data-base for members who may have been exposed to asbestos at work. 

It is highly recommended that members who believe they have been exposed to asbestos complete a Statutory Declaration and lodge it with the Institute, you can download a copy of the form here.


Test For Early Detection of Mesothelioma.

The mesothelioma research team at WA's Sir Charles Gairdner Hospital, has developed a blood test which will help to detect the onset of the deadly asbestos related lung cancer mesothelioma. The head of the team Professor Bruce Robinson said it would not only help in diagnosis of the disease but also in treatment. "Until now you could only gauge whether the treatment was working effectively by doing a CAT scan, and they're difficult to do. With this test, we can gauge treatment and also diagnose the disease at an earlier stage," Professor Robinson said.

Around 700 Australians are diagnosed with the disease every year and WA has the highest rate of mesothelioma in the world.


Guidance on the prohibition of asbestos is here; Seacare guidance on prohibition of asbestos Seacare guidance on prohibition of asbestos (118.87 KB)


Asbestos Diseases Foundation of Australia here

 

Asbestos Diseases Society of Australia here


SCHEDULE 2: SUBSTANCES PROHIBITED FOR SPECIFIED USES

Amosite asbestos [Chemical Abstract Number 12172-73-5] (brown asbestos) - except for removal and disposal purposes and situations where amosite occurs naturally and is not used for any new application.
NOTE: This prohibition is identical to that applied to this substance under the NOHSC National Model Regulations for the Control of Scheduled Carcinogenic Substances [NOHSC:1011(1995)]

Chrysotile asbestos [Chemical Abstract Number 12001-29-5] (white asbestos) - all uses from 31 December 2003, including the replacement of chrysotile products when replacement is necessary, except:
- for bona fide research or analysis;
- when handled for storage awaiting disposal;
- for removal or disposal; or
- where encountered during non-asbestos mining.
The prohibition does not extend to the removal of chrysotile products in situ at the time prohibition takes effect.

List of exemptions can be found here...

Crocidolite asbestos [Chemical Abstract Number 12001-28-4] (blue asbestos) - except for removal and disposal purposes and situations where crocidolite occurs naturally and is not used for any new application.
NOTE: This prohibition is identical to that applied to this substance under the NOHSC National Model Regulations for the Control of Scheduled Carcinogenic Substances [NOHSC:1011(1995)]

Actinolite asbestos [Chemical Abstract Number 77536-66-4] — except for situations where actinolite occurs naturally and is not used for any new application.

Anthophyllite asbestos [Chemical Abstract Number 77536-67-5] — except for situations where anthophyllite occurs naturally and is not used for any new application.

Tremolite asbestos [Chemical Abstract Number 77536-68-6] — except for situations where tremolite occurs naturally and is not used for any new application.

A list of hazardous substances and usages subject to prohibition is to be developed by the National Commission. Pending the development of this list, jurisdictions are to insert existing prohibitions in this schedule.